| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 30.719 | 34.779 | 45.519 | 51.584 | 54.319 | 66.032 | 65.874 |
| Total Income - EUR | - | - | - | 30.719 | 34.780 | 47.890 | 51.584 | 54.319 | 67.462 | 67.212 |
| Total Expenses - EUR | - | - | - | 16.250 | 19.699 | 36.162 | 28.293 | 28.058 | 24.084 | 24.352 |
| Gross Profit/Loss - EUR | - | - | - | 14.469 | 15.080 | 11.728 | 23.291 | 26.261 | 43.378 | 42.860 |
| Net Profit/Loss - EUR | - | - | - | 14.162 | 14.732 | 11.301 | 22.775 | 25.718 | 42.861 | 40.843 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Sancardio Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 28.836 | 19.802 | 11.065 | 2.775 | 0 | 8.443 |
| Current Assets | - | - | - | 15.940 | 26.077 | 31.472 | 59.328 | 31.915 | 48.370 | 37.427 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 11.406 | 22.224 | 14.993 | 11.931 | 6.942 | 11.365 | 1.207 |
| Cash | - | - | - | 4.534 | 3.853 | 16.479 | 47.397 | 4.695 | 16.788 | 7.472 |
| Shareholders Funds | - | - | - | 14.205 | 28.662 | 39.419 | 61.320 | 25.758 | 42.901 | 40.884 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.736 | 26.251 | 11.855 | 9.072 | 8.931 | 5.468 | 4.987 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sancardio Med S.r.l.